The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer, according to the Vanderbilt University Medical Center study ...

First patient treated in Phase II portion of clinical trial in metastatic prostate cancer at the West Los Angeles Veterans Administration ...

INmune Bio (INMB) has an ongoing Phase I/II trial in men with metastatic castration-resistant prostate cancer. The Company announced the ...